Nat Simons Becton Dickinson & CO Transaction History

Meritage Group LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$51.03 - $264.23 $19,238 - $99,614	377 Added 32.61%	1,533 $342,000
Q2 2022 Aug 12, 2022	BUY	$234.74 - $275.42 $271,359 - $318,385	1,156 New	1,156 $285,000
Q1 2021 May 14, 2021	SELL	$232.09 - $256.88 $233,714 - $258,678	-1,007 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$221.92 - $245.94 $223,473 - $247,661	1,007 New	1,007 $252,000

1,737

250M

690K

787K

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $63.9B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

Get notified when there are updates to the investment portfolio of Meritage Group LP, based on Form 13F filings with the SEC.

Stay updated on Meritage Group LP and Nat Simons with notifications on news.